Nefazodone

WikiDoc Resources for Nefazodone
Articles
Most recent articles on Nefazodone Most cited articles on Nefazodone Review articles on Nefazodone Articles on Nefazodone in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Nefazodone Images of Nefazodone Photos of Nefazodone Podcasts & MP3s on Nefazodone Videos on Nefazodone
Evidence Based Medicine
Cochrane Collaboration on Nefazodone Bandolier on Nefazodone TRIP on Nefazodone
Clinical Trials
Ongoing Trials on Nefazodone at Clinical Trials.gov Trial results on Nefazodone Clinical Trials on Nefazodone at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Nefazodone NICE Guidance on Nefazodone NHS PRODIGY Guidance FDA on Nefazodone CDC on Nefazodone
Books
Books on Nefazodone
News
Nefazodone in the news Be alerted to news on Nefazodone News trends on Nefazodone
Commentary
Blogs on Nefazodone
Definitions
Definitions of Nefazodone
Patient Resources / Community
Patient resources on Nefazodone Discussion groups on Nefazodone Patient Handouts on Nefazodone Directions to Hospitals Treating Nefazodone Risk calculators and risk factors for Nefazodone
Healthcare Provider Resources
Symptoms of Nefazodone Causes & Risk Factors for Nefazodone Diagnostic studies for Nefazodone Treatment of Nefazodone
Continuing Medical Education (CME)
CME Programs on Nefazodone
International
Nefazodone en Espanol Nefazodone en Francais
Business
Nefazodone in the Marketplace Patents on Nefazodone
Experimental / Informatics
List of terms related to Nefazodone

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Synonyms / Brand Names: Nefazodona, Nefazodone Hcl, Nefazodone hydrochloride, Nefazodonum, Dutonin, Serzone

Dosing and Administration

The recommended starting dose for Nefazodone hydrochloride tablets is 200 mg/day, administered in two divided doses (BID). In the controlled clinical trials establishing the antidepressant efficacy of Nefazodone, the effective dose range was generally 300 to 600 mg/day. Consequently, most patients, depending on tolerability and the need for further clinical effect, should have their dose increased. Dose increases should occur in increments of 100 mg/day to 200 mg/day, again on a BID schedule, at intervals of no less than 1 week. As with all antidepressants, several weeks on treatment may be required to obtain a full antidepressant response.

---

Adapted from the FDA Package Insert. Template:SIB Template:WH